Abstract Background Age is a critical driver of the worldwide increasing cancer incidence rates, and with the growing number of older adults diagnosed with cancer, there is a rising need for specialized care. However, geriatric oncology (GO) education remains underrepresented in medical curricula. The gap between demand and adequately trained providers requires the development of more robust GO training programs. This study examined the current state of GO education, and the areas of interest within GO and the expected teaching methods for this specialized content. Methods A multi-center international online survey aimed at assessing the awareness and perceived significance of GO among early-career medical students and nursing trainees was conducted. Results Among 158 participants, only 36.5% had oncology training and 19.6% geriatrics training. Despite this, GO was consistently rated as highly important, with no difference by prior GO training (p = 0.853). Participants expressed strongest interest in mental health, palliative care, and quality-of-care topics, while satisfaction with current training was moderate. Teaching was predominantly lecture-based, although more interactive approaches such as seminars and bedside teaching were preferred. Over half of participants were willing to contribute to improving GO education through feedback or volunteering. Conclusion GO remains underrepresented in current training despite its high perceived importance among trainees. Participants preferred interactive teaching formats, particularly seminars and bedside teaching, and showed strong interest in mental health and palliative care topics. These findings support integrating geriatric oncology into curricula using more practice-oriented teaching strategies.
Introduction: Periprosthetic joint infection (PJI) after total joint arthroplasty (TJA) poses substantial economic and quality-of-life challenges. With the rising incidence of hip and knee arthritis globally, understanding the changing profile of PJIs across different age groups becomes crucial. While various studies have explored risk factors, the influence of age on PJI remains debated, with potential bimodal relationships. This study aims to investigate the causative organisms of PJIs in patients of different age groups undergoing TJA. Methods: Conducted as a retrospective cohort study at a high-volume PJI referral center, the study adhered to Strengthening the Reporting of Observational Studies in Epidemiology guidelines. Data spanned from January 1, 2001, to December 31, 2022, including patients with documented PJI undergoing revision TJA. Patients were categorized into age quintiles, and outcomes analyzed included causative organisms, difficult-to-treat infections, antimicrobial resistance, and Gram stain characteristics. Statistical analyses used descriptive statistics, chi-square tests, and sensitivity analyses for hip and knee patients separately. Results: The study comprised 2,392 patients, with 60.7% undergoing hip arthroplasty and 39.3% undergoing knee arthroplasty. 1,080 women (45.2%) and 1,312 men (54.8%) were included. Older patients were markedly more likely to have gram-negative infections and atypical infections. Patients in the youngest age group had the lowest rates of methicillin-resistant Staphylococcus aureus infection. Results were similar between hip and knee PJIs. Conclusions: The study reveals age-related variations in the characteristics of PJIs after TJA, emphasizing higher risks of atypical and resistant infections in older patients. These findings underscore the importance of tailored preventive measures and potential considerations for adjunctive or prolonged antibiotic therapies, especially in the elderly population. Recognizing the unique infection patterns in older patients may inform better prevention and treatment strategies, with implications for enhanced patient care and outcomes. Future directions should focus on patient-specific strategies for preventing and treating PJIs, particularly in high-risk populations.
Management of perioperative pain in older adults can be challenging. Multimorbidity, functional decline or diminished physiological reserves, the corresponding polypharmacy, age-related pharmacodynamic and pharmacokinetic changes need to be considered. Pain assessment can be complicated by cognitive impairment and communication barriers. Older adults are at high risk of adverse consequences from surgery and undertreated pain as well as pharmacological overtreatment. Effective pain control in the perioperative period needs to be balanced against potential pharmacological harm. The aim of the orthogeriatric working group is to provide a practical guide for pain management in the perioperative orthogeriatric setting. It is supposed to be safe, effective and patient-centered. The set of expert recommendations is based on a current literature review, on the fit for the aged (FORTA )list expert consensus validation 2021 (4th edition), the PRISCUS list 2.0 of potentially inappropriate medications for older patients as well as on expert opinion and best clinical practice. Adequate analgesia is best achieved by applying multimodal analgesia. Various groups of analgesics are combined with interprofessional nonpharmacological treatment approaches. This article focuses on the pharmacological management of perioperative pain. Adequate analgesia can improve the overall outcome of orthogeriatric patients.
Transcatheter edge-to-edge mitral valve repair (M-TEER) is an established treatment for secondary mitral regurgitation (MR). Forward stroke volume (FSV), reflecting left ventricular forward flow, is a prognostic marker in heart failure and valvular disease. However, its clinical relevance in secondary MR has not been clearly defined. To assess the impact of M-TEER on FSV in atrial and ventricular secondary MR, identify predictors of FSV improvement, and evaluate its association with long-term outcomes. In this retrospective single-center study, 103 patients with moderate-to-severe or severe secondary MR (ventricular MR: n = 60, atrial MR: n = 43) underwent M-TEER. FSV was quantified using left ventricular outflow tract measurements before and 4 weeks post-procedure. Clinical outcomes were assessed over a 2-year follow-up period. Procedural success (MR grade ≤ II) was high (ventricular MR: 95
IntroductionAntimicrobial resistance in bacterial and fungal pathogens poses a major threat to global health, with Candida auris recently classified by the WHO as a critical priority pathogen. Antimicrobial peptides (AMPs) have emerged as promising candidates due to their broad-spectrum activity and membrane-disruptive mechanisms.MethodsIn this study, the antibacterial and antifungal efficacy of two CLEC3A-derived peptides, HT-47 and WRK-30, was evaluated in comparison to the reference AMP LL-37 and the drugs amphotericin B and penicillin/streptomycin using viable count assays, biofilm assays, and scanning and transmission electron microscopy.ResultsHT-47 and WRK-30 showed antibacterial activity against the ESKAPE pathogens K. pneumoniae and A. baumannii, as well as antifungal effects against C. albicans, C. neoformans, and particularly C. auris, with MIC50 values comparable to or lower than amphotericin B. Both peptides significantly inhibited more potent C. auris biofilm formation, compared to amphotericin B. SEM and TEM revealed extensive membrane and subcellular damage in peptide-treated fungal cells.ConclusionCLEC3A-derived peptides HT-47 and WRK-30 exhibit potent and comparable antibacterial and antifungal activity, highlighting their potential as therapeutic candidates for combating multidrug-resistant pathogens, including C. auris.